Scientists believe a pharmaceutical version of a naturally occurring peptide could protect lungs from coronavirus
![Coronavirus lung scan.](https://cdn.mos.cms.futurecdn.net/viYtfMJty9eehT4EH7N6EM-1024-80.jpg)
While the pharmaceutical industry has mainly focused on developing antiviral drugs that can fight off coronavirus infections and vaccines, one biotech firm is working on a treatment that would protect a patient's lungs from COVID-19's worst effects, Stat News reports.
Scientists now have a clear sense that the virus enters a person's system through ACE2, an enzyme commonly found on the surface of lung cells. One of ACE2's jobs is to prevent inflammation, but when it's interrupted (as it is in coronavirus patients), it can no longer keep a peptide that constricts blood vessels, known as angiotensin II, in check. Normally, ACE2 would fend off angiotensin II by converting it to angiotensin-(1-7), another peptide that relaxes the vessels and reduces inflammation, protecting people from blood clots and oxidation, which some COVID-19 patients have suffered from.
Two scientists, Concepción Peiró, a professor of pharmacology at the Autonomous University of Madrid, and Salvador Moncada, a professor of clinical pharmacology at the University of Manchester, hypothesized that boosting angiotensin-(1-7) could protect patients' lungs, while the immune system took care of the virus on its own. Upon learning this, Rick Franklin, the CEO of Constant Therapeutics, informed the Peiró and Moncada of his company's pharmaceutical version of the naturally-occurring angiotensin-(1-7), and Columbia University is now launching a trial for the drug.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
As usual, the testing period will prove tricky, but there's a growing consensus that combating the unopposed angiotensin II could be a "good technique" in trying to protect patients' lungs from the virus, even if it doesn't stave off the infection itself. Read more at Stat News.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Will Trump lead to more or fewer nuclear weapons in the world?
Talking Points He wants denuclearization. But critics worry about proliferation.
By Joel Mathis, The Week US Published
-
Is Ye finally about to be canceled for good?
TODAY'S BIG QUESTION From doubling down on overt antisemitism and Nazi admiration to a series of alarming public appearances, the rap superstar and fashion mogul might have finally gone too far
By Rafi Schwartz, The Week US Published
-
Planning a trip? These are 3 budget-breaking mistakes to avoid.
The Explainer Don't accidentally inflate your travel costs
By Becca Stanek, The Week US Published
-
Scientists report optimal method to boil an egg
Speed Read It takes two temperatures of water to achieve and no fancy gadgets
By Peter Weber, The Week US Published
-
Europe records big leap in renewable energy
Speed Read Solar power overtook coal for the first time
By Peter Weber, The Week US Published
-
Blue Origin conducts 1st test flight of massive rocket
Speed Read The Jeff Bezos-founded space company conducted a mostly successful test flight of its 320-foot-tall New Glenn rocket
By Peter Weber, The Week US Published
-
US won its war on 'murder hornets,' officials say
Speed Read The announcement comes five years after the hornets were first spotted in the US
By Peter Weber, The Week US Published
-
Dark energy data suggest Einstein was right
Speed Read Albert Einstein's 1915 theory of general relativity has been proven correct, according to data collected by the Dark Energy Spectroscopic Instrument
By Peter Weber, The Week US Published
-
New DNA tests of Pompeii dead upend popular stories
Speed Read An analysis of skeletal remains reveals that some Mount Vesuvius victims have been wrongly identified
By Peter Weber, The Week US Published
-
NASA's Europa Clipper blasts off, seeking an ocean
Speed Read The ship is headed toward Jupiter on a yearslong journey
By Peter Weber, The Week US Published
-
Detailed map of fly's brain holds clues to human mind
Speed Read This remarkable fruit fly brain analysis will aid in future human brain research
By Peter Weber, The Week US Published